We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

30 hedge funds and large institutions have $38.5M invested in Biolase, Inc. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

4% less capital invested

Capital invested by funds: $40.1M → $38.5M (-$1.65M)

12% less funds holding

Funds holding: 34 → 30 (-4)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.75%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
3
Increased
5
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.18M
2
TMC
Trellus Management Company
Florida
+$308K
3
GIP
Granite Investment Partners
California
+$109K
4
Millennium Management
Millennium Management
New York
+$72.6K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$18.1K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$272K
2
Northern Trust
Northern Trust
Illinois
-$218K
3
Renaissance Technologies
Renaissance Technologies
New York
-$83K
4
VKH
Virtu KCG Holdings
New York
-$62K
5
Deutsche Bank
Deutsche Bank
Germany
-$54.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$17K – – –
GC
27
Guggenheim Capital
Illinois
$17K – – –
IA
28
IFP Advisors
Florida
$14K – – –
WS
29
Wedbush Securities
California
$14K – – –
Wells Fargo
30
Wells Fargo
California
$14K +$18.1K +1 New
Bank of America
31
Bank of America
North Carolina
$5K – – –
LTFS
32
Ladenburg Thalmann Financial Services
Florida
$4K – – –
Creative Planning
33
Creative Planning
Kansas
$3K -$18.1K -1 Closed
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$3K – – –
TRCT
35
Tower Research Capital (TRC)
New York
$3K – – –
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
BC
37
Barnett & Company
Tennessee
$1K – – –
FDCDDQ
38
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3 – – –
Renaissance Technologies
39
Renaissance Technologies
New York
– -$83K -5 Closed
VKH
40
Virtu KCG Holdings
New York
– -$62K -4 Closed
Citadel Advisors
41
Citadel Advisors
Florida
– -$36K -2 Closed
JFA
42
JNBA Financial Advisors
Minnesota
– -$2K – –
1
2

BIOL Hedge Fund Activity: Q1 2017 in Review

30 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2017, worth a combined $38.5M — down 4.1% from $40.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BIOL and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.

The largest buyer was BlackRock, opening a new position worth an estimated $2.18M. The largest seller was Consonance Capital Management, cutting an estimated $272K.

  • 30 institutional investors held Biolase, Inc. (BIOL) as of Q1 2017, down from 34 in Q4 2016.
  • Funds reported $38.5M of Biolase, Inc. stock for Q1 2017, down 4.1% quarter-over-quarter.
  • 3 funds opened new Biolase, Inc. positions in Q1 2017 and 4 closed out, a net change of -1 holder.
  • The largest Biolase, Inc. buyer in Q1 2017 was BlackRock, an estimated $2.18M added.
  • The largest Biolase, Inc. seller in Q1 2017 was Consonance Capital Management, an estimated $272K sold.

Based on aggregated 13F filings for Q1 2017.